Annual FCF
$4.79 B
-$21.24 B-81.59%
31 December 2023
Summary:
Pfizer annual free cash flow is currently $4.79 billion, with the most recent change of -$21.24 billion (-81.59%) on 31 December 2023. During the last 3 years, it has fallen by -$7.38 billion (-60.64%). PFE annual FCF is now -83.95% below its all-time high of $29.87 billion, reached on 31 December 2021.PFE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$6.06 B
+$8.48 B+350.74%
30 September 2024
Summary:
Pfizer quarterly free cash flow is currently $6.06 billion, with the most recent change of +$8.48 billion (+350.74%) on 30 September 2024. Over the past year, it has increased by +$3.42 billion (+129.14%). PFE quarterly FCF is now -43.66% below its all-time high of $10.76 billion, reached on 01 June 2021.PFE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$8.23 B
+$3.42 B+71.04%
30 September 2024
Summary:
Pfizer TTM free cash flow is currently $8.23 billion, with the most recent change of +$3.42 billion (+71.04%) on 30 September 2024. Over the past year, it has increased by +$49.00 million (+0.60%). PFE TTM FCF is now -74.12% below its all-time high of $31.78 billion, reached on 01 March 2022.PFE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.6% | +129.1% | +0.6% |
| 3 y3 years | -60.6% | -40.6% | -72.4% |
| 5 y5 years | -65.0% | +57.6% | -24.9% |
PFE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -84.0% | at low | -40.6% | +350.7% | -74.1% | +71.7% |
| 5 y | 5 years | -84.0% | at low | -43.7% | +350.7% | -74.1% | +71.7% |
| alltime | all time | -84.0% | +3509.2% | -43.7% | +191.0% | -74.1% | >+9999.0% |
Pfizer Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.06 B(-350.7%) | $8.23 B(+71.0%) |
| June 2024 | - | -$2.42 B(-726.4%) | $4.81 B(-5.8%) |
| Mar 2024 | - | $386.00 M(-90.8%) | $5.11 B(+6.5%) |
| Dec 2023 | $4.79 B(-81.6%) | $4.20 B(+58.6%) | $4.79 B(-41.4%) |
| Sept 2023 | - | $2.65 B(-224.7%) | $8.18 B(-23.3%) |
| June 2023 | - | -$2.12 B(-3006.8%) | $10.66 B(-47.2%) |
| Mar 2023 | - | $73.00 M(-99.0%) | $20.21 B(-22.4%) |
| Dec 2022 | $26.03 B(-12.8%) | $7.58 B(+47.7%) | $26.03 B(+11.4%) |
| Sept 2022 | - | $5.13 B(-30.8%) | $23.36 B(-17.9%) |
| June 2022 | - | $7.42 B(+25.8%) | $28.44 B(-10.5%) |
| Mar 2022 | - | $5.90 B(+20.1%) | $31.78 B(+6.4%) |
| Dec 2021 | $29.87 B(+145.3%) | $4.91 B(-51.9%) | $29.87 B(+0.3%) |
| Sept 2021 | - | $10.21 B(-5.1%) | $29.77 B(+40.8%) |
| June 2021 | - | $10.76 B(+170.1%) | $21.14 B(+56.9%) |
| Mar 2021 | - | $3.98 B(-17.2%) | $13.48 B(+10.7%) |
| Dec 2020 | $12.18 B(+15.5%) | $4.81 B(+204.0%) | $12.18 B(+11.1%) |
| Sept 2020 | - | $1.58 B(-48.9%) | $10.96 B(-17.1%) |
| June 2020 | - | $3.10 B(+15.4%) | $13.22 B(+8.9%) |
| Mar 2020 | - | $2.68 B(-25.3%) | $12.15 B(+15.2%) |
| Dec 2019 | $10.54 B(-23.0%) | $3.59 B(-6.7%) | $10.54 B(-3.8%) |
| Sept 2019 | - | $3.85 B(+90.2%) | $10.96 B(-7.2%) |
| June 2019 | - | $2.02 B(+87.3%) | $11.81 B(-10.6%) |
| Mar 2019 | - | $1.08 B(-73.0%) | $13.21 B(-3.5%) |
| Dec 2018 | $13.69 B(-6.1%) | $4.01 B(-14.7%) | $13.69 B(-14.4%) |
| Sept 2018 | - | $4.70 B(+37.2%) | $16.00 B(+2.6%) |
| June 2018 | - | $3.42 B(+118.7%) | $15.60 B(+4.5%) |
| Mar 2018 | - | $1.56 B(-75.2%) | $14.92 B(+2.3%) |
| Dec 2017 | $14.59 B(+2.8%) | $6.32 B(+47.2%) | $14.59 B(+7.7%) |
| Sept 2017 | - | $4.29 B(+56.0%) | $13.54 B(-0.1%) |
| June 2017 | - | $2.75 B(+124.4%) | $13.55 B(-2.6%) |
| Mar 2017 | - | $1.23 B(-76.7%) | $13.91 B(-2.0%) |
| Dec 2016 | $14.19 B(+7.6%) | $5.27 B(+22.5%) | $14.19 B(+7.9%) |
| Sept 2016 | - | $4.30 B(+38.5%) | $13.16 B(-2.9%) |
| June 2016 | - | $3.11 B(+106.3%) | $13.55 B(-5.0%) |
| Mar 2016 | - | $1.51 B(-64.4%) | $14.27 B(+8.1%) |
| Dec 2015 | $13.19 B(-14.9%) | $4.24 B(-9.8%) | $13.19 B(-6.8%) |
| Sept 2015 | - | $4.70 B(+22.7%) | $14.16 B(+5.9%) |
| June 2015 | - | $3.83 B(+781.8%) | $13.37 B(+0.5%) |
| Mar 2015 | - | $434.00 M(-91.7%) | $13.30 B(-14.2%) |
| Dec 2014 | $15.50 B(-4.4%) | $5.20 B(+33.3%) | $15.50 B(-0.1%) |
| Sept 2014 | - | $3.90 B(+3.8%) | $15.52 B(-9.7%) |
| June 2014 | - | $3.76 B(+42.5%) | $17.19 B(+1.8%) |
| Mar 2014 | - | $2.64 B(-49.5%) | $16.88 B(+4.1%) |
| Dec 2013 | $16.22 B(+5.8%) | $5.22 B(-6.2%) | $16.22 B(+5.6%) |
| Sept 2013 | - | $5.57 B(+61.6%) | $15.36 B(+5.9%) |
| June 2013 | - | $3.45 B(+74.5%) | $14.50 B(-1.9%) |
| Mar 2013 | - | $1.98 B(-54.7%) | $14.78 B(-3.6%) |
| Dec 2012 | $15.33 B(-16.5%) | $4.36 B(-7.5%) | $15.33 B(-0.5%) |
| Sept 2012 | - | $4.72 B(+26.6%) | $15.41 B(+5.0%) |
| June 2012 | - | $3.73 B(+47.9%) | $14.67 B(-11.0%) |
| Mar 2012 | - | $2.52 B(-43.3%) | $16.49 B(-10.2%) |
| Dec 2011 | $18.36 B(+84.7%) | $4.44 B(+11.4%) | $18.36 B(-6.5%) |
| Sept 2011 | - | $3.98 B(-28.1%) | $19.63 B(-10.9%) |
| June 2011 | - | $5.54 B(+26.1%) | $22.04 B(+5.0%) |
| Mar 2011 | - | $4.39 B(-23.1%) | $21.00 B(+111.2%) |
| Dec 2010 | $9.94 B(-35.4%) | $5.71 B(-10.7%) | $9.94 B(+15.2%) |
| Sept 2010 | - | $6.39 B(+42.1%) | $8.63 B(+42.0%) |
| June 2010 | - | $4.50 B(-167.5%) | $6.08 B(+4.4%) |
| Mar 2010 | - | -$6.67 B(-251.4%) | $5.82 B(-62.1%) |
| Dec 2009 | $15.38 B(-7.0%) | $4.40 B(+14.7%) | $15.38 B(-7.1%) |
| Sept 2009 | - | $3.84 B(-9.5%) | $16.56 B(+2.0%) |
| June 2009 | - | $4.25 B(+46.7%) | $16.23 B(-2.5%) |
| Mar 2009 | - | $2.89 B(-48.2%) | $16.64 B(+0.6%) |
| Dec 2008 | $16.54 B(+45.5%) | $5.58 B(+59.2%) | $16.54 B(+18.6%) |
| Sept 2008 | - | $3.51 B(-24.7%) | $13.95 B(-4.8%) |
| June 2008 | - | $4.66 B(+67.0%) | $14.66 B(+10.7%) |
| Mar 2008 | - | $2.79 B(-6.9%) | $13.24 B(+16.5%) |
| Dec 2007 | $11.36 B | $2.99 B(-29.0%) | $11.36 B(-5.9%) |
| Sept 2007 | - | $4.22 B(+30.3%) | $12.08 B(+6.7%) |
| June 2007 | - | $3.24 B(+254.2%) | $11.32 B(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $914.00 M(-75.4%) | $12.76 B(-17.1%) |
| Dec 2006 | $15.39 B(+21.9%) | $3.71 B(+7.2%) | $15.39 B(-2.6%) |
| Sept 2006 | - | $3.46 B(-25.9%) | $15.80 B(+6.4%) |
| June 2006 | - | $4.67 B(+31.9%) | $14.86 B(+10.5%) |
| Mar 2006 | - | $3.54 B(-14.1%) | $13.44 B(+6.5%) |
| Dec 2005 | $12.63 B(-8.1%) | $4.12 B(+63.8%) | $12.63 B(-5.9%) |
| Sept 2005 | - | $2.52 B(-22.7%) | $13.42 B(-13.5%) |
| June 2005 | - | $3.26 B(+19.4%) | $15.51 B(+1.0%) |
| Mar 2005 | - | $2.73 B(-44.5%) | $15.36 B(+11.8%) |
| Dec 2004 | $13.74 B(+51.0%) | $4.92 B(+6.6%) | $13.74 B(+10.4%) |
| Sept 2004 | - | $4.61 B(+48.6%) | $12.44 B(+23.9%) |
| June 2004 | - | $3.10 B(+179.2%) | $10.04 B(+21.7%) |
| Mar 2004 | - | $1.11 B(-69.3%) | $8.25 B(-9.3%) |
| Dec 2003 | $9.10 B(+8.0%) | $3.62 B(+63.3%) | $9.10 B(+4.8%) |
| Sept 2003 | - | $2.21 B(+69.0%) | $8.68 B(+3.1%) |
| June 2003 | - | $1.31 B(-32.9%) | $8.41 B(-8.7%) |
| Mar 2003 | - | $1.96 B(-38.8%) | $9.21 B(+9.4%) |
| Dec 2002 | $8.43 B(+19.2%) | $3.20 B(+63.9%) | $8.43 B(+19.9%) |
| Sept 2002 | - | $1.95 B(-7.6%) | $7.03 B(-1.3%) |
| June 2002 | - | $2.11 B(+81.0%) | $7.12 B(+3.9%) |
| Mar 2002 | - | $1.17 B(-35.2%) | $6.85 B(-3.1%) |
| Dec 2001 | $7.07 B(+76.5%) | $1.80 B(-11.9%) | $7.07 B(-4.4%) |
| Sept 2001 | - | $2.04 B(+10.4%) | $7.40 B(+5.9%) |
| June 2001 | - | $1.85 B(+33.5%) | $6.98 B(+20.6%) |
| Mar 2001 | - | $1.38 B(-34.9%) | $5.79 B(+44.6%) |
| Dec 2000 | $4.00 B(+34.4%) | $2.13 B(+30.8%) | $4.00 B(+21.7%) |
| Sept 2000 | - | $1.63 B(+148.1%) | $3.29 B(+17.1%) |
| June 2000 | - | $655.00 M(-262.9%) | $2.81 B(-8.1%) |
| Mar 2000 | - | -$402.00 M(-128.5%) | $3.05 B(+2.5%) |
| Dec 1999 | $2.98 B(-7.7%) | $1.41 B(+23.3%) | $2.98 B(-26.9%) |
| Sept 1999 | - | $1.14 B(+27.0%) | $4.08 B(+20.3%) |
| June 1999 | - | $901.00 M(-289.3%) | $3.39 B(+19.7%) |
| Mar 1999 | - | -$476.00 M(-119.0%) | $2.83 B(-12.3%) |
| Dec 1998 | $3.23 B(+387.9%) | $2.51 B(+449.0%) | $3.23 B(+270.4%) |
| Sept 1998 | - | $457.00 M(+33.2%) | $872.00 M(+30.3%) |
| June 1998 | - | $343.00 M(-534.2%) | $669.00 M(+26.9%) |
| Mar 1998 | - | -$79.00 M(-152.3%) | $527.00 M(-20.4%) |
| Dec 1997 | $662.00 M(-19.4%) | $151.00 M(-40.6%) | $662.00 M(+24.9%) |
| Sept 1997 | - | $254.00 M(+26.4%) | $530.00 M(-20.7%) |
| June 1997 | - | $201.00 M(+258.9%) | $668.00 M(-15.5%) |
| Mar 1997 | - | $56.00 M(+194.7%) | $791.00 M(-3.7%) |
| Dec 1996 | $821.00 M(-27.0%) | $19.00 M(-95.2%) | $821.00 M(-34.5%) |
| Sept 1996 | - | $392.00 M(+21.0%) | $1.25 B(+13.8%) |
| June 1996 | - | $324.00 M(+276.7%) | $1.10 B(+29.7%) |
| Mar 1996 | - | $86.00 M(-81.0%) | $849.70 M(-24.5%) |
| Dec 1995 | $1.13 B(+37.7%) | $451.70 M(+88.1%) | $1.13 B(+17.1%) |
| Sept 1995 | - | $240.10 M(+233.9%) | $960.90 M(+2.6%) |
| June 1995 | - | $71.90 M(-80.1%) | $936.60 M(-11.7%) |
| Mar 1995 | - | $361.40 M(+25.7%) | $1.06 B(+29.9%) |
| Dec 1994 | $817.00 M(+29.9%) | $287.50 M(+33.2%) | $817.00 M(-18.8%) |
| Sept 1994 | - | $215.80 M(+9.8%) | $1.01 B(+3.9%) |
| June 1994 | - | $196.60 M(+67.9%) | $967.90 M(+14.7%) |
| Mar 1994 | - | $117.10 M(-75.4%) | $844.20 M(+34.3%) |
| Dec 1993 | $628.80 M(+373.5%) | $476.40 M(+167.9%) | $628.80 M(+121.8%) |
| Sept 1993 | - | $177.80 M(+143.9%) | $283.50 M(+50.4%) |
| June 1993 | - | $72.90 M(-174.2%) | $188.50 M(+39.2%) |
| Mar 1993 | - | -$98.30 M(-175.0%) | $135.40 M(+2.0%) |
| Dec 1992 | $132.80 M(-47.7%) | $131.10 M(+58.3%) | $132.80 M(-27.7%) |
| Sept 1992 | - | $82.80 M(+318.2%) | $183.80 M(+52.8%) |
| June 1992 | - | $19.80 M(-119.6%) | $120.30 M(-37.3%) |
| Mar 1992 | - | -$100.90 M(-155.4%) | $191.90 M(-24.4%) |
| Dec 1991 | $253.80 M(-18.9%) | $182.10 M(+843.5%) | $253.80 M(-20.8%) |
| Sept 1991 | - | $19.30 M(-78.9%) | $320.60 M(+16.1%) |
| June 1991 | - | $91.40 M(-334.4%) | $276.10 M(+4.2%) |
| Mar 1991 | - | -$39.00 M(-115.7%) | $264.90 M(-15.4%) |
| Dec 1990 | $313.00 M(+57.0%) | $248.90 M(-1087.7%) | $313.00 M(+388.3%) |
| Sept 1990 | - | -$25.20 M(-131.4%) | $64.10 M(-28.2%) |
| June 1990 | - | $80.20 M(+781.3%) | $89.30 M(+881.3%) |
| Mar 1990 | - | $9.10 M | $9.10 M |
| Dec 1989 | $199.30 M | - | - |
FAQ
- What is Pfizer annual free cash flow?
- What is the all time high annual FCF for Pfizer?
- What is Pfizer annual FCF year-on-year change?
- What is Pfizer quarterly free cash flow?
- What is the all time high quarterly FCF for Pfizer?
- What is Pfizer quarterly FCF year-on-year change?
- What is Pfizer TTM free cash flow?
- What is the all time high TTM FCF for Pfizer?
- What is Pfizer TTM FCF year-on-year change?
What is Pfizer annual free cash flow?
The current annual FCF of PFE is $4.79 B
What is the all time high annual FCF for Pfizer?
Pfizer all-time high annual free cash flow is $29.87 B
What is Pfizer annual FCF year-on-year change?
Over the past year, PFE annual free cash flow has changed by -$21.24 B (-81.59%)
What is Pfizer quarterly free cash flow?
The current quarterly FCF of PFE is $6.06 B
What is the all time high quarterly FCF for Pfizer?
Pfizer all-time high quarterly free cash flow is $10.76 B
What is Pfizer quarterly FCF year-on-year change?
Over the past year, PFE quarterly free cash flow has changed by +$3.42 B (+129.14%)
What is Pfizer TTM free cash flow?
The current TTM FCF of PFE is $8.23 B
What is the all time high TTM FCF for Pfizer?
Pfizer all-time high TTM free cash flow is $31.78 B
What is Pfizer TTM FCF year-on-year change?
Over the past year, PFE TTM free cash flow has changed by +$49.00 M (+0.60%)